Gerald V. Denis, PhD

Associate Professor, Hematology & Medical Oncology, Cancer Center Co-Director, Boston University School of Medicine

  • Title Associate Professor, Hematology & Medical Oncology, Cancer Center Co-Director, Boston University School of Medicine
  • Education MSc, University of Tokyo; PhD, University of California, Berkeley

Dr. Denis’s research lab at the BU-BMC Cancer Center has pioneered studies of the BET bromodomains proteins, a family comprised of BRD2, BRD3 and BRD4 in somatic cells, which are important as transcriptional co-regulators that control prostate and breast cancer progression. He is particularly concerned about rising rates of obesity and its associated metabolic diseases, such as Type 2 diabetes, which are inflammatory conditions that increase tumor progression in both androgen-independent prostate cancer and triple negative breast cancer. His lab investigates new small molecule approaches to block the relevant pathways and reduce risk of metastasis in patients with co-morbid obesity and diabetes. Dr. Denis is thrilled to join the Shipley Center team in finding new discoveries and developing new therapies for prostate cancer.

Learn more about Dr. Denis.